Literature DB >> 18635828

Mesenchymal stem cell-derived IL-10 and recovery from infarction: a third pitch for the chord.

Nanette H Bishopric.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18635828      PMCID： PMC2726265          DOI： 10.1161/CIRCRESAHA.108.180596

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  18 in total

1.  High-dose cellular IL-10 exacerbates rejection and reverses effects of cyclosporine and tacrolimus in Mouse cardiac transplantation.

Authors:  W Li; L Lu; Y Li; F Fu; J J Fung; A W Thomson; S Qian
Journal:  Transplant Proc       Date:  1997 Feb-Mar       Impact factor: 1.066

2.  Lipid-mediated gene transfer of viral IL-10 prolongs vascularized cardiac allograft survival by inhibiting donor-specific cellular and humoral immune responses.

Authors:  L A DeBruyne; K Li; S Y Chan; L Qin; D K Bishop; J S Bromberg
Journal:  Gene Ther       Date:  1998-08       Impact factor: 5.250

3.  Systemic administration of cellular interleukin-10 can exacerbate cardiac allograft rejection in mice.

Authors:  S Qian; W Li; Y Li; F Fu; L Lu; J J Fung; A W Thomson
Journal:  Transplantation       Date:  1996-12-27       Impact factor: 4.939

4.  Human mesenchymal stem cells modulate allogeneic immune cell responses.

Authors:  Sudeepta Aggarwal; Mark F Pittenger
Journal:  Blood       Date:  2004-10-19       Impact factor: 22.113

5.  Recombinant adenovirus-transduced human dendritic cells engineered to secrete interleukin-10 (IL-10) suppress Th1-type responses while selectively activating IL-10-producing CD4+ T cells.

Authors:  Delphine Rea; Drake Laface; Beth Hutchins; Kitty Kwappenberg; Cornelis J M Melief; Rob C Hoeben; Rienk Offringa
Journal:  Hum Immunol       Date:  2004-11       Impact factor: 2.850

6.  Bone marrow cells regenerate infarcted myocardium.

Authors:  D Orlic; J Kajstura; S Chimenti; I Jakoniuk; S M Anderson; B Li; J Pickel; R McKay; B Nadal-Ginard; D M Bodine; A Leri; P Anversa
Journal:  Nature       Date:  2001-04-05       Impact factor: 49.962

7.  Interleukin-10 from transplanted bone marrow mononuclear cells contributes to cardiac protection after myocardial infarction.

Authors:  Jana S Burchfield; Masayoshi Iwasaki; Masamichi Koyanagi; Carmen Urbich; Nadia Rosenthal; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Circ Res       Date:  2008-06-19       Impact factor: 17.367

8.  Heart transplants in interferon-gamma, interleukin 4, and interleukin 10 knockout mice. Recipient environment alters graft rejection.

Authors:  A Räisänen-Sokolowski; P L Mottram; T Glysing-Jensen; A Satoskar; M E Russell
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

9.  Viral interleukin-10 gene therapy to induce tolerance to solid organ transplants in mice.

Authors:  S K Salgar; D Yang; P Ruiz; J Miller; A G Tzakis
Journal:  Transplant Proc       Date:  2004-03       Impact factor: 1.066

10.  Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells.

Authors:  H Jonuleit; E Schmitt; G Schuler; J Knop; A H Enk
Journal:  J Exp Med       Date:  2000-11-06       Impact factor: 14.307
View more
  6 in total

1.  Interleukin-10 deficiency impairs bone marrow-derived endothelial progenitor cell survival and function in ischemic myocardium.

Authors:  Prasanna Krishnamurthy; Melissa Thal; Suresh Verma; Eneda Hoxha; Erin Lambers; Veronica Ramirez; Gangjian Qin; Douglas Losordo; Raj Kishore
Journal:  Circ Res       Date:  2011-09-29       Impact factor: 17.367

Review 2.  Stem cell-based therapies in ischemic heart diseases: a focus on aspects of microcirculation and inflammation.

Authors:  Junxi Wu; Jun Li; Nannan Zhang; Cuihua Zhang
Journal:  Basic Res Cardiol       Date:  2011-03-23       Impact factor: 17.165

Review 3.  Bone marrow mesenchymal stem cells for post-myocardial infarction cardiac repair: microRNAs as novel regulators.

Authors:  Zhuzhi Wen; Shaoxin Zheng; Changqing Zhou; Woliang Yuan; Jingfeng Wang; Tong Wang
Journal:  J Cell Mol Med       Date:  2012-04       Impact factor: 5.310

Review 4.  The Current Dilemma and Breakthrough of Stem Cell Therapy in Ischemic Heart Disease.

Authors:  Chuanbin Liu; Dong Han; Ping Liang; Yang Li; Feng Cao
Journal:  Front Cell Dev Biol       Date:  2021-04-22

Review 5.  Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction.

Authors:  Zhuzhi Wen; Shaoxin Zheng; Changqing Zhou; Jingfeng Wang; Tong Wang
Journal:  J Cell Mol Med       Date:  2011-05       Impact factor: 5.310

6.  Novel mechanism of inhibition of dendritic cells maturation by mesenchymal stem cells via interleukin-10 and the JAK1/STAT3 signaling pathway.

Authors:  Wen-hua Liu; Jing-jin Liu; Jian Wu; Lu-lu Zhang; Fang Liu; Li Yin; Mao-mao Zhang; Bo Yu
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.